Nakamoto Nobuhiro, Schnabl Bernd
Department of Medicine, Keio University, Tokyo, Japan.
Department of Medicine, University of California, San Diego, La Jolla, Calif., USA; Department of Medicine, VA San Diego Healthcare System, San Diego, Calif., USA.
Inflamm Intest Dis. 2016 Apr;1(1):3-8. doi: 10.1159/000443196. Epub 2016 Jan 20.
Changes in bacterial communities are associated with the pathogenesis of many diseases including inflammatory bowel disease and liver disease. Dysbiosis can induce intestinal inflammation resulting in increased intestinal permeability and bacterial translocation. The majority of chronic liver diseases are associated with bacterial translocation resulting in or enhancing an inflammatory response in the liver. Intestinal inflammation and a dysfunctional intestinal barrier are not sufficient to cause liver disease in the absence of an additional liver insult. In this article, the authors summarize differences in intestinal microbiota composition between Eastern and Western countries. The authors specifically discuss whether differences in microbiota composition could explain the epidemiological differences in liver disease found in Asia and Europe/the USA.
细菌群落的变化与包括炎症性肠病和肝病在内的许多疾病的发病机制相关。生态失调可诱发肠道炎症,导致肠道通透性增加和细菌易位。大多数慢性肝病与细菌易位相关,从而导致或增强肝脏中的炎症反应。在没有额外肝脏损伤的情况下,肠道炎症和功能失调的肠道屏障不足以引发肝病。在本文中,作者总结了东西方国家肠道微生物群组成的差异。作者特别讨论了微生物群组成的差异是否可以解释在亚洲和欧洲/美国发现的肝病流行病学差异。